Abstract
Introduction. SARS-CoV-2 associated multi-systemic inflammation syndrome represents a pathology with diverse symptomatology, the pediatric population in question developing fever for longer than three days, with high inflammatory markers values, and being susceptible to gastrointestinal, cutaneous and mucosal tissue, cardiac or respiratory manifestations. The objective of this paper is to highlight the importance of dosing inflammatory cardiac markers (NT-proBNP, CK-MB) and of performing an echocardiographic examination when evaluating a patient with post-COVID-19 inflammatory status, and to point out the main treatment recommendations in European or American guides. Discussion. The medical literature describes cases of coronary artery dilation in teenagers, but it is more often seen in school-age children. The treatment in the mentioned studies consists primarily of aspirin, cortisone and intravenous immunoglobulin, and in some cases, antibiotics were offered. Conclusions. When confronted with a patient who is at a high risk of developing or experiencing multisystem inflammatory syndrome associated with SARS-CoV-2, it is imperative to evaluate the cardiac function, with laboratory and imaging tests.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
